4-amino-3-chloro-N-[1-[2-[[(2S)-1,4-dioxopentan-2-yl]amino]-2-oxoethyl]-2-oxo-5-phenyl-3H-1,4-benzodiazepin-3-yl]benzamide;N-[[1-[2-[[(2S)-1,4-dioxopentan-2-yl]amino]-2-oxoethyl]-2-oxo-5-phenyl-3H-1,4-benzodiazepin-3-yl]carbamoyl]benzamide;N-[1-[2-[[(2S)-1,4-dioxopentan-2-yl]amino]-2-oxoethyl]-2-oxo-5-phenyl-3H-1,4-benzodiazepin-3-yl]cyclohexanecarboxamide;N-[1-[2-[[(2S)-1,4-dioxopentan-2-yl]amino]-2-oxoethyl]-2-oxo-5-phenyl-3H-1,4-benzodiazepin-3-yl]-2-phenylacetamide;N-[1-[2-[[(2S)-1,4-dioxopentan-2-yl]amino]-2-oxoethyl]-2-oxo-5-phenyl-3H-1,4-benzodiazepin-3-yl]-3-phenylpropanamide;N-[(2S)-1,4-dioxopentan-2-yl]-2-[2-oxo-5-phenyl-3-(phenylcarbamoylamino)-3H-1,4-benzodiazepin-1-yl]acetamide

C178H170ClN27O31 — CID 90839644

About 4-amino-3-chloro-N-[1-[2-[[(2S)-1,4-dioxopentan-2-yl]amino]-2-oxoethyl]-2-oxo-5-phenyl-3H-1,4-benzodiazepin-3-yl]benzamide;N-[[1-[2-[[(2S)-1,4-dioxopentan-2-yl]amino]-2-oxoethyl]-2-oxo-5-phenyl-3H-1,4-benzodiazepin-3-yl]carbamoyl]benzamide;N-[1-[2-[[(2S)-1,4-dioxopentan-2-yl]amino]-2-oxoethyl]-2-oxo-5-phenyl-3H-1,4-benzodiazepin-3-yl]cyclohexanecarboxamide;N-[1-[2-[[(2S)-1,4-dioxopentan-2-yl]amino]-2-oxoethyl]-2-oxo-5-phenyl-3H-1,4-benzodiazepin-3-yl]-2-phenylacetamide;N-[1-[2-[[(2S)-1,4-dioxopentan-2-yl]amino]-2-oxoethyl]-2-oxo-5-phenyl-3H-1,4-benzodiazepin-3-yl]-3-phenylpropanamide;N-[(2S)-1,4-dioxopentan-2-yl]-2-[2-oxo-5-phenyl-3-(phenylcarbamoylamino)-3H-1,4-benzodiazepin-1-yl]acetamide

4-amino-3-chloro-N-[1-[2-[[(2S)-1,4-dioxopentan-2-yl]amino]-2-oxoethyl]-2-oxo-5-phenyl-3H-1,4-benzodiazepin-3-yl]benzamide;N-[[1-[2-[[(2S)-1,4-dioxopentan-2-yl]amino]-2-oxoethyl]-2-oxo-5-phenyl-3H-1,4-benzodiazepin-3-yl]carbamoyl]benzamide;N-[1-[2-[[(2S)-1,4-dioxopentan-2-yl]amino]-2-oxoethyl]-2-oxo-5-phenyl-3H-1,4-benzodiazepin-3-yl]cyclohexanecarboxamide;N-[1-[2-[[(2S)-1,4-dioxopentan-2-yl]amino]-2-oxoethyl]-2-oxo-5-phenyl-3H-1,4-benzodiazepin-3-yl]-2-phenylacetamide;N-[1-[2-[[(2S)-1,4-dioxopentan-2-yl]amino]-2-oxoethyl]-2-oxo-5-phenyl-3H-1,4-benzodiazepin-3-yl]-3-phenylpropanamide;N-[(2S)-1,4-dioxopentan-2-yl]-2-[2-oxo-5-phenyl-3-(phenylcarbamoylamino)-3H-1,4-benzodiazepin-1-yl]acetamide (PubChem CID 90839644) has the molecular formula C178H170ClN27O31 and a molecular weight of 3218.93 g/mol. Its IUPAC name is 4-amino-3-chloro-N-[1-[2-[[(2S)-1,4-dioxopentan-2-yl]amino]-2-oxoethyl]-2-oxo-5-phenyl-3H-1,4-benzodiazepin-3-yl]benzamide;N-[[1-[2-[[(2S)-1,4-dioxopentan-2-yl]amino]-2-oxoethyl]-2-oxo-5-phenyl-3H-1,4-benzodiazepin-3-yl]carbamoyl]benzamide;N-[1-[2-[[(2S)-1,4-dioxopentan-2-yl]amino]-2-oxoethyl]-2-oxo-5-phenyl-3H-1,4-benzodiazepin-3-yl]cyclohexanecarboxamide;N-[1-[2-[[(2S)-1,4-dioxopentan-2-yl]amino]-2-oxoethyl]-2-oxo-5-phenyl-3H-1,4-benzodiazepin-3-yl]-2-phenylacetamide;N-[1-[2-[[(2S)-1,4-dioxopentan-2-yl]amino]-2-oxoethyl]-2-oxo-5-phenyl-3H-1,4-benzodiazepin-3-yl]-3-phenylpropanamide;N-[(2S)-1,4-dioxopentan-2-yl]-2-[2-oxo-5-phenyl-3-(phenylcarbamoylamino)-3H-1,4-benzodiazepin-1-yl]acetamide.

Molecular Properties

• Compound Name: 4-amino-3-chloro-N-[1-[2-[[(2S)-1,4-dioxopentan-2-yl]amino]-2-oxoethyl]-2-oxo-5-phenyl-3H-1,4-benzodiazepin-3-yl]benzamide;N-[[1-[2-[[(2S)-1,4-dioxopentan-2-yl]amino]-2-oxoethyl]-2-oxo-5-phenyl-3H-1,4-benzodiazepin-3-yl]carbamoyl]benzamide;N-[1-[2-[[(2S)-1,4-dioxopentan-2-yl]amino]-2-oxoethyl]-2-oxo-5-phenyl-3H-1,4-benzodiazepin-3-yl]cyclohexanecarboxamide;N-[1-[2-[[(2S)-1,4-dioxopentan-2-yl]amino]-2-oxoethyl]-2-oxo-5-phenyl-3H-1,4-benzodiazepin-3-yl]-2-phenylacetamide;N-[1-[2-[[(2S)-1,4-dioxopentan-2-yl]amino]-2-oxoethyl]-2-oxo-5-phenyl-3H-1,4-benzodiazepin-3-yl]-3-phenylpropanamide;N-[(2S)-1,4-dioxopentan-2-yl]-2-[2-oxo-5-phenyl-3-(phenylcarbamoylamino)-3H-1,4-benzodiazepin-1-yl]acetamide
• PubChem CID: 90839644
• Molecular Formula: C178H170ClN27O31
• Molecular Weight: 3218.93 g/mol
• Exact Mass: 3216.22
• IUPAC Name: 4-amino-3-chloro-N-[1-[2-[[(2S)-1,4-dioxopentan-2-yl]amino]-2-oxoethyl]-2-oxo-5-phenyl-3H-1,4-benzodiazepin-3-yl]benzamide;N-[[1-[2-[[(2S)-1,4-dioxopentan-2-yl]amino]-2-oxoethyl]-2-oxo-5-phenyl-3H-1,4-benzodiazepin-3-yl]carbamoyl]benzamide;N-[1-[2-[[(2S)-1,4-dioxopentan-2-yl]amino]-2-oxoethyl]-2-oxo-5-phenyl-3H-1,4-benzodiazepin-3-yl]cyclohexanecarboxamide;N-[1-[2-[[(2S)-1,4-dioxopentan-2-yl]amino]-2-oxoethyl]-2-oxo-5-phenyl-3H-1,4-benzodiazepin-3-yl]-2-phenylacetamide;N-[1-[2-[[(2S)-1,4-dioxopentan-2-yl]amino]-2-oxoethyl]-2-oxo-5-phenyl-3H-1,4-benzodiazepin-3-yl]-3-phenylpropanamide;N-[(2S)-1,4-dioxopentan-2-yl]-2-[2-oxo-5-phenyl-3-(phenylcarbamoylamino)-3H-1,4-benzodiazepin-1-yl]acetamide
• SMILES: CC(=O)C[C@@H](C=O)NC(=O)CN1C(=O)C(NC(=O)C2CCCCC2)N=C(c2ccccc2)c2ccccc21.CC(=O)C[C@@H](C=O)NC(=O)CN1C(=O)C(NC(=O)CCc2ccccc2)N=C(c2ccccc2)c2ccccc21.CC(=O)C[C@@H](C=O)NC(=O)CN1C(=O)C(NC(=O)Cc2ccccc2)N=C(c2ccccc2)c2ccccc21.CC(=O)C[C@@H](C=O)NC(=O)CN1C(=O)C(NC(=O)NC(=O)c2ccccc2)N=C(c2ccccc2)c2ccccc21.CC(=O)C[C@@H](C=O)NC(=O)CN1C(=O)C(NC(=O)Nc2ccccc2)N=C(c2ccccc2)c2ccccc21.CC(=O)C[C@@H](C=O)NC(=O)CN1C(=O)C(NC(=O)c2ccc(N)c(Cl)c2)N=C(c2ccccc2)c2ccccc21
• InChI: InChI=1S/C31H30N4O5.C30H27N5O6.C30H28N4O5.C29H26ClN5O5.C29H27N5O5.C29H32N4O5/c1-21(37)18-24(20-36)32-28(39)19-35-26-15-9-8-14-25(26)29(23-12-6-3-7-13-23)34-30(31(35)40)33-27(38)17-16-22-10-4-2-5-11-22;1-19(37)16-22(18-36)31-25(38)17-35-24-15-9-8-14-23(24)26(20-10-4-2-5-11-20)32-27(29(35)40)33-30(41)34-28(39)21-12-6-3-7-13-21;1-20(36)16-23(19-35)31-27(38)18-34-25-15-9-8-14-24(25)28(22-12-6-3-7-13-22)33-29(30(34)39)32-26(37)17-21-10-4-2-5-11-21;1-17(37)13-20(16-36)32-25(38)15-35-24-10-6-5-9-21(24)26(18-7-3-2-4-8-18)33-27(29(35)40)34-28(39)19-11-12-23(31)22(30)14-19;1-19(36)16-22(18-35)30-25(37)17-34-24-15-9-8-14-23(24)26(20-10-4-2-5-11-20)32-27(28(34)38)33-29(39)31-21-12-6-3-7-13-21;1-19(35)16-22(18-34)30-25(36)17-33-24-15-9-8-14-23(24)26(20-10-4-2-5-11-20)31-27(29(33)38)32-28(37)21-12-6-3-7-13-21/h2-15,20,24,30H,16-19H2,1H3,(H,32,39)(H,33,38);2-15,18,22,27H,16-17H2,1H3,(H,31,38)(H2,33,34,39,41);2-15,19,23,29H,16-18H2,1H3,(H,31,38)(H,32,37);2-12,14,16,20,27H,13,15,31H2,1H3,(H,32,38)(H,34,39);2-15,18,22,27H,16-17H2,1H3,(H,30,37)(H2,31,33,39);2,4-5,8-11,14-15,18,21-22,27H,3,6-7,12-13,16-17H2,1H3,(H,30,36)(H,32,37)/t24-,30?;22-,27?;23-,29?;20-,27?;2*22-,27?/m000000/s1
• InChIKey: LXDDUYNNSZDXAE-MPCHUQQMSA-N
• XLogP: 14.59
• TPSA: 817.21 Ų
• H-Bond Donors: 15
• H-Bond Acceptors: 38
• Rotatable Bonds: 57
• Heavy Atoms: 237
• Complexity: —

Lipinski Rule of Five

4 violations

Rule	Value
MW ≤ 500	3218.93
LogP ≤ 5	14.59
H-Bond Donors ≤ 5	15
H-Bond Acceptors ≤ 10	38

Computed Properties (RDKit)

• Structural Alerts: {'alert_name': 'aldehyde', 'substructure': 'N/A'}, {'alert_name': 'aniline', 'substructure': 'N/A'}

Frequently Asked Questions

What is the IUPAC name of 4-amino-3-chloro-N-[1-[2-[[(2S)-1,4-dioxopentan-2-yl]amino]-2-oxoethyl]-2-oxo-5-phenyl-3H-1,4-benzodiazepin-3-yl]benzamide;N-[[1-[2-[[(2S)-1,4-dioxopentan-2-yl]amino]-2-oxoethyl]-2-oxo-5-phenyl-3H-1,4-benzodiazepin-3-yl]carbamoyl]benzamide;N-[1-[2-[[(2S)-1,4-dioxopentan-2-yl]amino]-2-oxoethyl]-2-oxo-5-phenyl-3H-1,4-benzodiazepin-3-yl]cyclohexanecarboxamide;N-[1-[2-[[(2S)-1,4-dioxopentan-2-yl]amino]-2-oxoethyl]-2-oxo-5-phenyl-3H-1,4-benzodiazepin-3-yl]-2-phenylacetamide;N-[1-[2-[[(2S)-1,4-dioxopentan-2-yl]amino]-2-oxoethyl]-2-oxo-5-phenyl-3H-1,4-benzodiazepin-3-yl]-3-phenylpropanamide;N-[(2S)-1,4-dioxopentan-2-yl]-2-[2-oxo-5-phenyl-3-(phenylcarbamoylamino)-3H-1,4-benzodiazepin-1-yl]acetamide?

The IUPAC name of 4-amino-3-chloro-N-[1-[2-[[(2S)-1,4-dioxopentan-2-yl]amino]-2-oxoethyl]-2-oxo-5-phenyl-3H-1,4-benzodiazepin-3-yl]benzamide;N-[[1-[2-[[(2S)-1,4-dioxopentan-2-yl]amino]-2-oxoethyl]-2-oxo-5-phenyl-3H-1,4-benzodiazepin-3-yl]carbamoyl]benzamide;N-[1-[2-[[(2S)-1,4-dioxopentan-2-yl]amino]-2-oxoethyl]-2-oxo-5-phenyl-3H-1,4-benzodiazepin-3-yl]cyclohexanecarboxamide;N-[1-[2-[[(2S)-1,4-dioxopentan-2-yl]amino]-2-oxoethyl]-2-oxo-5-phenyl-3H-1,4-benzodiazepin-3-yl]-2-phenylacetamide;N-[1-[2-[[(2S)-1,4-dioxopentan-2-yl]amino]-2-oxoethyl]-2-oxo-5-phenyl-3H-1,4-benzodiazepin-3-yl]-3-phenylpropanamide;N-[(2S)-1,4-dioxopentan-2-yl]-2-[2-oxo-5-phenyl-3-(phenylcarbamoylamino)-3H-1,4-benzodiazepin-1-yl]acetamide (CID 90839644) is 4-amino-3-chloro-N-[1-[2-[[(2S)-1,4-dioxopentan-2-yl]amino]-2-oxoethyl]-2-oxo-5-phenyl-3H-1,4-benzodiazepin-3-yl]benzamide;N-[[1-[2-[[(2S)-1,4-dioxopentan-2-yl]amino]-2-oxoethyl]-2-oxo-5-phenyl-3H-1,4-benzodiazepin-3-yl]carbamoyl]benzamide;N-[1-[2-[[(2S)-1,4-dioxopentan-2-yl]amino]-2-oxoethyl]-2-oxo-5-phenyl-3H-1,4-benzodiazepin-3-yl]cyclohexanecarboxamide;N-[1-[2-[[(2S)-1,4-dioxopentan-2-yl]amino]-2-oxoethyl]-2-oxo-5-phenyl-3H-1,4-benzodiazepin-3-yl]-2-phenylacetamide;N-[1-[2-[[(2S)-1,4-dioxopentan-2-yl]amino]-2-oxoethyl]-2-oxo-5-phenyl-3H-1,4-benzodiazepin-3-yl]-3-phenylpropanamide;N-[(2S)-1,4-dioxopentan-2-yl]-2-[2-oxo-5-phenyl-3-(phenylcarbamoylamino)-3H-1,4-benzodiazepin-1-yl]acetamide.

What is the SMILES notation for 4-amino-3-chloro-N-[1-[2-[[(2S)-1,4-dioxopentan-2-yl]amino]-2-oxoethyl]-2-oxo-5-phenyl-3H-1,4-benzodiazepin-3-yl]benzamide;N-[[1-[2-[[(2S)-1,4-dioxopentan-2-yl]amino]-2-oxoethyl]-2-oxo-5-phenyl-3H-1,4-benzodiazepin-3-yl]carbamoyl]benzamide;N-[1-[2-[[(2S)-1,4-dioxopentan-2-yl]amino]-2-oxoethyl]-2-oxo-5-phenyl-3H-1,4-benzodiazepin-3-yl]cyclohexanecarboxamide;N-[1-[2-[[(2S)-1,4-dioxopentan-2-yl]amino]-2-oxoethyl]-2-oxo-5-phenyl-3H-1,4-benzodiazepin-3-yl]-2-phenylacetamide;N-[1-[2-[[(2S)-1,4-dioxopentan-2-yl]amino]-2-oxoethyl]-2-oxo-5-phenyl-3H-1,4-benzodiazepin-3-yl]-3-phenylpropanamide;N-[(2S)-1,4-dioxopentan-2-yl]-2-[2-oxo-5-phenyl-3-(phenylcarbamoylamino)-3H-1,4-benzodiazepin-1-yl]acetamide?

The canonical SMILES for 4-amino-3-chloro-N-[1-[2-[[(2S)-1,4-dioxopentan-2-yl]amino]-2-oxoethyl]-2-oxo-5-phenyl-3H-1,4-benzodiazepin-3-yl]benzamide;N-[[1-[2-[[(2S)-1,4-dioxopentan-2-yl]amino]-2-oxoethyl]-2-oxo-5-phenyl-3H-1,4-benzodiazepin-3-yl]carbamoyl]benzamide;N-[1-[2-[[(2S)-1,4-dioxopentan-2-yl]amino]-2-oxoethyl]-2-oxo-5-phenyl-3H-1,4-benzodiazepin-3-yl]cyclohexanecarboxamide;N-[1-[2-[[(2S)-1,4-dioxopentan-2-yl]amino]-2-oxoethyl]-2-oxo-5-phenyl-3H-1,4-benzodiazepin-3-yl]-2-phenylacetamide;N-[1-[2-[[(2S)-1,4-dioxopentan-2-yl]amino]-2-oxoethyl]-2-oxo-5-phenyl-3H-1,4-benzodiazepin-3-yl]-3-phenylpropanamide;N-[(2S)-1,4-dioxopentan-2-yl]-2-[2-oxo-5-phenyl-3-(phenylcarbamoylamino)-3H-1,4-benzodiazepin-1-yl]acetamide is CC(=O)C[C@@H](C=O)NC(=O)CN1C(=O)C(NC(=O)C2CCCCC2)N=C(c2ccccc2)c2ccccc21.CC(=O)C[C@@H](C=O)NC(=O)CN1C(=O)C(NC(=O)CCc2ccccc2)N=C(c2ccccc2)c2ccccc21.CC(=O)C[C@@H](C=O)NC(=O)CN1C(=O)C(NC(=O)Cc2ccccc2)N=C(c2ccccc2)c2ccccc21.CC(=O)C[C@@H](C=O)NC(=O)CN1C(=O)C(NC(=O)NC(=O)c2ccccc2)N=C(c2ccccc2)c2ccccc21.CC(=O)C[C@@H](C=O)NC(=O)CN1C(=O)C(NC(=O)Nc2ccccc2)N=C(c2ccccc2)c2ccccc21.CC(=O)C[C@@H](C=O)NC(=O)CN1C(=O)C(NC(=O)c2ccc(N)c(Cl)c2)N=C(c2ccccc2)c2ccccc21.

What is the InChIKey of 4-amino-3-chloro-N-[1-[2-[[(2S)-1,4-dioxopentan-2-yl]amino]-2-oxoethyl]-2-oxo-5-phenyl-3H-1,4-benzodiazepin-3-yl]benzamide;N-[[1-[2-[[(2S)-1,4-dioxopentan-2-yl]amino]-2-oxoethyl]-2-oxo-5-phenyl-3H-1,4-benzodiazepin-3-yl]carbamoyl]benzamide;N-[1-[2-[[(2S)-1,4-dioxopentan-2-yl]amino]-2-oxoethyl]-2-oxo-5-phenyl-3H-1,4-benzodiazepin-3-yl]cyclohexanecarboxamide;N-[1-[2-[[(2S)-1,4-dioxopentan-2-yl]amino]-2-oxoethyl]-2-oxo-5-phenyl-3H-1,4-benzodiazepin-3-yl]-2-phenylacetamide;N-[1-[2-[[(2S)-1,4-dioxopentan-2-yl]amino]-2-oxoethyl]-2-oxo-5-phenyl-3H-1,4-benzodiazepin-3-yl]-3-phenylpropanamide;N-[(2S)-1,4-dioxopentan-2-yl]-2-[2-oxo-5-phenyl-3-(phenylcarbamoylamino)-3H-1,4-benzodiazepin-1-yl]acetamide?

The InChIKey is LXDDUYNNSZDXAE-MPCHUQQMSA-N. The full InChI is InChI=1S/C31H30N4O5.C30H27N5O6.C30H28N4O5.C29H26ClN5O5.C29H27N5O5.C29H32N4O5/c1-21(37)18-24(20-36)32-28(39)19-35-26-15-9-8-14-25(26)29(23-12-6-3-7-13-23)34-30(31(35)40)33-27(38)17-16-22-10-4-2-5-11-22;1-19(37)16-22(18-36)31-25(38)17-35-24-15-9-8-14-23(24)26(20-10-4-2-5-11-20)32-27(29(35)40)33-30(41)34-28(39)21-12-6-3-7-13-21;1-20(36)16-23(19-35)31-27(38)18-34-25-15-9-8-14-24(25)28(22-12-6-3-7-13-22)33-29(30(34)39)32-26(37)17-21-10-4-2-5-11-21;1-17(37)13-20(16-36)32-25(38)15-35-24-10-6-5-9-21(24)26(18-7-3-2-4-8-18)33-27(29(35)40)34-28(39)19-11-12-23(31)22(30)14-19;1-19(36)16-22(18-35)30-25(37)17-34-24-15-9-8-14-23(24)26(20-10-4-2-5-11-20)32-27(28(34)38)33-29(39)31-21-12-6-3-7-13-21;1-19(35)16-22(18-34)30-25(36)17-33-24-15-9-8-14-23(24)26(20-10-4-2-5-11-20)31-27(29(33)38)32-28(37)21-12-6-3-7-13-21/h2-15,20,24,30H,16-19H2,1H3,(H,32,39)(H,33,38);2-15,18,22,27H,16-17H2,1H3,(H,31,38)(H2,33,34,39,41);2-15,19,23,29H,16-18H2,1H3,(H,31,38)(H,32,37);2-12,14,16,20,27H,13,15,31H2,1H3,(H,32,38)(H,34,39);2-15,18,22,27H,16-17H2,1H3,(H,30,37)(H2,31,33,39);2,4-5,8-11,14-15,18,21-22,27H,3,6-7,12-13,16-17H2,1H3,(H,30,36)(H,32,37)/t24-,30?;22-,27?;23-,29?;20-,27?;2*22-,27?/m000000/s1.

What are the key properties of 4-amino-3-chloro-N-[1-[2-[[(2S)-1,4-dioxopentan-2-yl]amino]-2-oxoethyl]-2-oxo-5-phenyl-3H-1,4-benzodiazepin-3-yl]benzamide;N-[[1-[2-[[(2S)-1,4-dioxopentan-2-yl]amino]-2-oxoethyl]-2-oxo-5-phenyl-3H-1,4-benzodiazepin-3-yl]carbamoyl]benzamide;N-[1-[2-[[(2S)-1,4-dioxopentan-2-yl]amino]-2-oxoethyl]-2-oxo-5-phenyl-3H-1,4-benzodiazepin-3-yl]cyclohexanecarboxamide;N-[1-[2-[[(2S)-1,4-dioxopentan-2-yl]amino]-2-oxoethyl]-2-oxo-5-phenyl-3H-1,4-benzodiazepin-3-yl]-2-phenylacetamide;N-[1-[2-[[(2S)-1,4-dioxopentan-2-yl]amino]-2-oxoethyl]-2-oxo-5-phenyl-3H-1,4-benzodiazepin-3-yl]-3-phenylpropanamide;N-[(2S)-1,4-dioxopentan-2-yl]-2-[2-oxo-5-phenyl-3-(phenylcarbamoylamino)-3H-1,4-benzodiazepin-1-yl]acetamide?

4-amino-3-chloro-N-[1-[2-[[(2S)-1,4-dioxopentan-2-yl]amino]-2-oxoethyl]-2-oxo-5-phenyl-3H-1,4-benzodiazepin-3-yl]benzamide;N-[[1-[2-[[(2S)-1,4-dioxopentan-2-yl]amino]-2-oxoethyl]-2-oxo-5-phenyl-3H-1,4-benzodiazepin-3-yl]carbamoyl]benzamide;N-[1-[2-[[(2S)-1,4-dioxopentan-2-yl]amino]-2-oxoethyl]-2-oxo-5-phenyl-3H-1,4-benzodiazepin-3-yl]cyclohexanecarboxamide;N-[1-[2-[[(2S)-1,4-dioxopentan-2-yl]amino]-2-oxoethyl]-2-oxo-5-phenyl-3H-1,4-benzodiazepin-3-yl]-2-phenylacetamide;N-[1-[2-[[(2S)-1,4-dioxopentan-2-yl]amino]-2-oxoethyl]-2-oxo-5-phenyl-3H-1,4-benzodiazepin-3-yl]-3-phenylpropanamide;N-[(2S)-1,4-dioxopentan-2-yl]-2-[2-oxo-5-phenyl-3-(phenylcarbamoylamino)-3H-1,4-benzodiazepin-1-yl]acetamide has a molecular weight of 3218.93 g/mol, XLogP of 14.59, 57 rotatable bonds, 15 hydrogen bond donors, and 38 hydrogen bond acceptors.

Where does this data come from?

All data for 4-amino-3-chloro-N-[1-[2-[[(2S)-1,4-dioxopentan-2-yl]amino]-2-oxoethyl]-2-oxo-5-phenyl-3H-1,4-benzodiazepin-3-yl]benzamide;N-[[1-[2-[[(2S)-1,4-dioxopentan-2-yl]amino]-2-oxoethyl]-2-oxo-5-phenyl-3H-1,4-benzodiazepin-3-yl]carbamoyl]benzamide;N-[1-[2-[[(2S)-1,4-dioxopentan-2-yl]amino]-2-oxoethyl]-2-oxo-5-phenyl-3H-1,4-benzodiazepin-3-yl]cyclohexanecarboxamide;N-[1-[2-[[(2S)-1,4-dioxopentan-2-yl]amino]-2-oxoethyl]-2-oxo-5-phenyl-3H-1,4-benzodiazepin-3-yl]-2-phenylacetamide;N-[1-[2-[[(2S)-1,4-dioxopentan-2-yl]amino]-2-oxoethyl]-2-oxo-5-phenyl-3H-1,4-benzodiazepin-3-yl]-3-phenylpropanamide;N-[(2S)-1,4-dioxopentan-2-yl]-2-[2-oxo-5-phenyl-3-(phenylcarbamoylamino)-3H-1,4-benzodiazepin-1-yl]acetamide is sourced from PubChem (CID 90839644), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).